title: Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population.
abstract: Deficient activity of the Dihydropteridine Reductase enzyme (DHPR; EC 1.5.1.34; OMIM 261630) is due to mutations in the Quinoid Dihydropteridine Reductase gene on 4p15.3 (QDPR; RefSeq NM_000320). It results in defective recycling of tetrahydrobiopterin (BH(4)) and homozygotes have a rare form of atypical Hyperphenylalaninaemia and Phenylketonuria (aPKU). The heterozygote frequency in the Maltese population is high at 3.3%. The more recently described and rarer type of BH(4) deficiency due to Sepiapterin Reductase enzyme deficiency (SR; EC 1.1.1.153; OMIM 182125), which presents as an atypical form of Dopa Responsive Dystonia (DRD) [L. Bonafe, B. Thony, J.M. Penzien, B. Czarnecki, N. Blau, Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia, Am. J. Hum. Genet. 69 (2001) 269-277; B.R.G. Neville, R. Parascandalo, S. Attard Montalto, R. Farrugia, A.E. Felice, A congenital dopa responsive motor disorder: a Maltese variant due to sepiapterin reductase deficiency, Brain 128 (Pt10) (2005) 2291-2296.] has also been identified at high frequency (4.6%) in this population. Two mutations, the c.68G>A in QDPR (p.G23D), and the new SPR, IVS2-2A>G mutation at the splice site consensus sequence in intron 2 of the Sepiapterin Reductase gene (SPR; RefSeq NM_003124) on 2p14-p12, were found to be the sole causative mutations in all the patients with DHPR deficiency and SR deficiency studied. All parents were heterozygotes for the corresponding mutation and showed no clinical symptoms. Three polymorphisms, c.96C>T (p.A32A), c. 345G>A (p.S115S) and c. 396G>A (p.L132L), have also been identified in the QDPR gene, defining four wild-type frameworks, useful in molecular epidemiology studies. The c. 68G>A mutation in QDPR was found only on framework I, suggesting a founder effect. In contrast no additional sequence diversity was found in the SPR gene whether in wild-type or mutant alleles which is also consistent with a founder effect.
authors.affiliation: Laboratory of Molecular Genetics, Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
authors.forename: Rosienne
authors.initials: R
authors.lastname: Farrugia
authors.forename: Christian A
authors.initials: CA
authors.lastname: Scerri
authors.forename: Simon Attard
authors.initials: SA
authors.lastname: Montalto
authors.forename: Raymond
authors.initials: R
authors.lastname: Parascandolo
authors.forename: Brian G R
authors.initials: BG
authors.lastname: Neville
authors.forename: Alex E
authors.initials: AE
authors.lastname: Felice
mesh_terms: D000429:Alcohol Oxidoreductases / Q000172:deficiency / Q000235:genetics; D000483:Alleles; D001483:Base Sequence; D001708:Biopterins / Q000031:analogs & derivatives* / Q000172:deficiency; D017931:DNA Primers / Q000235:genetics; D004093:Dihydropteridine Reductase / Q000235:genetics; D005787:Gene Frequency; D006801:Humans; D007223:Infant; D008297:Male; D008319:Malta; D008967:Molecular Biology; D009154:Mutation; D010661:Phenylketonurias / Q000235:genetics* / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D001708:Biopterins; D000429:Alcohol Oxidoreductases; C022630:sepiapterin reductase; D004093:Dihydropteridine Reductase; C003402:sapropterin